| 摘要 |
A method for treating an autism spectrum condition includes administering an effective dose of a TNF-αinhibiting agent to a person having an autism spectrum condition or pervasive development disorder and at least one of elevated TNF-αin the cerebrospinal fluid or elevated TNF-αin the serum, as compared to normal conditions; and lowering at least one of the elevated TNF-αin the cerebrospinal fluid or elevated TNF-αin the serum. A TNF-αinhibiting agent includes at least one of Lenalinomide; Thalidomide; L-Carnosine; Infliximab; Etanercept; a stem cell preparation; derivatives thereof, isomers thereof, or pharmaceutically acceptable salts thereof.
|
